Review



glucose sensors  (Dexcom Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Dexcom Inc glucose sensors
    Glucose Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g7+glucose+sensors/pm21722574-24-17-22
    Average 86 stars, based on 1 article reviews
    glucose sensors - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Challenges of Wearable Biosensors and Ways to Overcome Them.
    Article Snippet: For example, Dexcom G7 glucose sensors sold have a shorter warm-up period of about 30 min, FreeStyle Libre sensors often take about an hour, and, for example, the Medtronic Guardian device requires a two-hour warm-up period.

    Article Title: Challenges of Wearable Biosensors and Ways to Overcome Them
    Article Snippet: For example, Dexcom G7 glucose sensors sold have a shorter warm-up period of about 30 min, FreeStyle Libre sensors often take about an hour, and, for example, the Medtronic Guardian device requires a two-hour warm-up period.

    Article Title: Accuracy of a Continuous Glucose Monitor in the Intensive Care Unit.
    Article Snippet: Objectives: Continuous glucose monitoring (CGM) devices are routinely used in the outpatient management of diabetes.. They are not yet approved for use in intensive care units (ICUs).. The main objective of this study was to determine the accuracy of CGM glucose determinations made in an ICU by comparing them with standard glucose measurements obtained during routine care.

    Article Title: Allergic Contact Dermatitis From Medical Adhesive Tape Used for Friction Blister Prevention in the Norwegian Armed Forces: A Case Series.
    Article Snippet: Background: Colophony and its derivatives are common allergens.. Contact dermatitis from colophonycontaining adhesive tapes for blister prevention has previously been reported among Swedish conscripts.. Objectives: To present the investigation of suspected allergic contact dermatitis among Norwegian military personnel exposed to medical adhesive tapes during service.

    In Vivo:

    Article Title: Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages.
    Article Snippet: Female ICR (CD-1) mice ranging from 21–50 g in weight were utilized for these in vivo studies and were obtained from Harlan (Indianapolis, IN). .. Navigator glucose sensors utilized in these in vivo studies were obtained from Abbott Diabetes Care, and Seven glucose sensors were obtained from DexCom, Inc. Glucose sensors were implanted into mice, and CGM was followed as described with modifications.4,5 For sensor implantation, a small volume of saline (50–100 μl) was injected subcutaneously at the location for sensor implantation utilizing a 26 ga needle. ..

    Saline:

    Article Title: Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages.
    Article Snippet: Female ICR (CD-1) mice ranging from 21–50 g in weight were utilized for these in vivo studies and were obtained from Harlan (Indianapolis, IN). .. Navigator glucose sensors utilized in these in vivo studies were obtained from Abbott Diabetes Care, and Seven glucose sensors were obtained from DexCom, Inc. Glucose sensors were implanted into mice, and CGM was followed as described with modifications.4,5 For sensor implantation, a small volume of saline (50–100 μl) was injected subcutaneously at the location for sensor implantation utilizing a 26 ga needle. ..

    Injection:

    Article Title: Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages.
    Article Snippet: Female ICR (CD-1) mice ranging from 21–50 g in weight were utilized for these in vivo studies and were obtained from Harlan (Indianapolis, IN). .. Navigator glucose sensors utilized in these in vivo studies were obtained from Abbott Diabetes Care, and Seven glucose sensors were obtained from DexCom, Inc. Glucose sensors were implanted into mice, and CGM was followed as described with modifications.4,5 For sensor implantation, a small volume of saline (50–100 μl) was injected subcutaneously at the location for sensor implantation utilizing a 26 ga needle. ..



    Similar Products

    dexcom cgm sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom cgm sensor
    Dexcom Cgm Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/cgm+sensors/pm42156180-52-2-2
    Average 86 stars, based on 1 article reviews
    dexcom cgm sensor - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    dexcom g7 cgm sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g7 cgm sensor
    Dexcom G7 Cgm Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g7+sensor/pm42156180-106-2-2
    Average 86 stars, based on 1 article reviews
    dexcom g7 cgm sensor - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    dexcom g4 platinum sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g4 platinum sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom G4 Platinum Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g4+platinum/med_rxiv__64898__2026__05__13__26353094-140-16-16
    Average 86 stars, based on 1 article reviews
    dexcom g4 platinum sensor - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    dexcom sensors  (Dexcom Inc)
    86
    Dexcom Inc dexcom sensors
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+sensors/med_rxiv__64898__2026__05__13__26353094-32-26-26
    Average 86 stars, based on 1 article reviews
    dexcom sensors - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    dexcom g6 sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g6 sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom G6 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g6+sensor/pm42108404-47-3-6
    Average 86 stars, based on 1 article reviews
    dexcom g6 sensor - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    unblinded dexcom g7 sensor  (Dexcom Inc)
    86
    Dexcom Inc unblinded dexcom g7 sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Unblinded Dexcom G7 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g7+sensor/pm42092238-19-34-35
    Average 86 stars, based on 1 article reviews
    unblinded dexcom g7 sensor - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    dexcom g7 sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g7 sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom G7 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g7+sensor/pmc13128380-112-1-1
    Average 86 stars, based on 1 article reviews
    dexcom g7 sensor - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    dexcom sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+sensor/pmc13065641-82-22-22
    Average 86 stars, based on 1 article reviews
    dexcom sensor - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    dexcom g4 sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g4 sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom G4 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g4+sensor/pmc13065641-63-9-9
    Average 86 stars, based on 1 article reviews
    dexcom g4 sensor - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom G4 Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.

    Journal: medRxiv

    Article Title: Prevalence, duration, and clinical implications of Continuous Glucose Monitor (CGM) measurement limit capping in type 1 diabetes

    doi: 10.64898/2026.05.13.26353094

    Figure Lengend Snippet: Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom G4 Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.

    Article Snippet: Our BGM comparison is restricted to a single arm of a single trial using the older Dexcom G4 Platinum sensor (mean absolute relative difference (MARD) ∼14%), which has lower accuracy than the Dexcom G6 (MARD ∼9%) used in three of our four datasets.

    Techniques: Software